These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL. Kobayashi T; Kamoto T; Nishizawa K; Mitsumori K; Ogura K; Ide Y BJU Int; 2005 Apr; 95(6):761-5. PubMed ID: 15794778 [TBL] [Abstract][Full Text] [Related]
29. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer]. de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075 [TBL] [Abstract][Full Text] [Related]
30. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. Christensson A; Björk T; Nilsson O; Dahlén U; Matikainen MT; Cockett AT; Abrahamsson PA; Lilja H J Urol; 1993 Jul; 150(1):100-5. PubMed ID: 7685416 [TBL] [Abstract][Full Text] [Related]
31. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis. Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657 [TBL] [Abstract][Full Text] [Related]
32. [Factors affecting the PSA:alpha 1 antichymotrypsin/total PSA ratio]. Martínez Sarmiento M; España F; Royo M; Estellés A; Aznar J; Peinado F; Alapont JM; Vera Donoso CD; Jiménez Cruz JF Actas Urol Esp; 2001 May; 25(5):350-6. PubMed ID: 11512259 [TBL] [Abstract][Full Text] [Related]
33. Reference ranges for the concentrations of total and complexed plasma prostate-specific antigen and their ratio in patients with benign prostate hyperplasia. España F; Martínez M; Royo M; Vera CD; Estellés A; Aznar J; Jiménez-Cruz JF Eur Urol; 1997; 32(3):268-72. PubMed ID: 9358211 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer. Froehner M; Hakenberg OW; Koch R; Schmidt U; Meye A; Wirth MP Urol Int; 2006; 76(1):27-30. PubMed ID: 16401917 [TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. Okihara K; Cheli CD; Partin AW; Fritche HA; Chan DW; Sokoll LJ; Brawer MK; Schwartz MK; Vessella RL; Loughlin KR; Johnston DA; Babaian RJ J Urol; 2002 May; 167(5):2017-23; discussion 2023-4. PubMed ID: 11956430 [TBL] [Abstract][Full Text] [Related]
36. Predicting the extent of prostate cancer using a combination of serum prostate-specific antigen-alpha(1)-antichymotrypsin complex and systematic biopsy. Miyake H; Hara S; Yamanaka N; Ono Y; Eto H; Yamada Y; Takechi Y; Arakawa S; Kamidono S; Hara I Urol Int; 2002; 68(4):232-6. PubMed ID: 12053023 [TBL] [Abstract][Full Text] [Related]
37. Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA. Van Cangh PJ; De Nayer P; De Vischer L; Sauvage P; Tombal B; Lorge F; Wese FX; Opsomer R Urology; 1996 Dec; 48(6A Suppl):67-70. PubMed ID: 8973703 [TBL] [Abstract][Full Text] [Related]
38. [Study of free to total prostate specific antigen ratio in the detection of patients with prostate cancer]. Ohuchi H; Mikata K; Miyoshi Y; Ohta J; Osada Y; Uemura H; Yao M; Takeda M; Noguchi S; Kubota Y; Hosaka M; Jinza S; Asakura T; Ebato T Nihon Hinyokika Gakkai Zasshi; 2000 Dec; 91(12):695-9. PubMed ID: 11201129 [TBL] [Abstract][Full Text] [Related]
39. Ratio of prostate specific antigen minor molecular forms-to-total prostate specific antigen is constant regardless of the pathological condition of the prostate. Kobayashi T; Kamoto T; Isogawa Y; Kinoshita H; Terai A; Habuchi T; Ogawa O J Urol; 2003 Jan; 169(1):121-4. PubMed ID: 12478118 [TBL] [Abstract][Full Text] [Related]
40. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer. Okegawa T; Noda H; Nutahara K; Higashihara E Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]